Presentation

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Presenter: S. Lee

July 11, 2012

REGISTER for free or LOG IN to view this content

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Policy & Practice

Prevention

CAD Pharma

Clinical Pharma

Coronary

Stroke

Factoid

Up Next

Presentation

Systematic Review and Cost-Benefit Analysis of Radial Artery Access for Coronary Angiography

Presenter: Matthew D. Mitchell

July 12, 2012

More slides +

Presentation

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Presenter: Ryota Sakurai

July 12, 2012

Presentation

Comparison of Results of CABG vs. PCI in Octogenarians

Presenter: 84194|Julian Gunn

July 13, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.